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Abstract
Background: Periodontal diseases may affect local and systemic inflammation, and reactive oxygen species (ROS)
levels. This systemic health burden could compromise the outcome of pregnancy in expectant mothers. The aim of
the present study was to evaluate oxidative stress markers, including glutathione peroxidase (GPx), thiobarbituric
acid-reactive substances (TBARS) and 8-hydroxy-2’-deoxyguanosine (8-OHdG), and total bacterial loads in the saliva
of pregnant and postpartum women, and to investigate their association with periodontal disease severity.
Methods: A total of 187 women were originally recruited for this case–control study, assigned to the following
groups a) pregnant group, b) postpartum group: the pregnant group re-evaluated 6 months after giving birth, c)
control group: systemically healthy and non-pregnant women. The levels of the studied oxidative stress markers in
saliva were measured by commercially available kits.
Results: The levels of salivary 8-OHdG were significantly elevated in the pregnant, compared with the control
group. Although salivary 8-OHdG levels slightly decreased after giving birth (postpartum group), the difference did
not reach significance. In contrast, the activity of antioxidant enzyme GPx in saliva was significantly lower in the
pregnant than the control group. Although no differences in lipid peroxidation (represented by TBARS) were observed
between the pregnant and control groups, after giving birth TBARS levels were significantly lowered. Only in the
postpartum and control groups did clinical measurements of periodontal disease severity correlate with oxidative stress
markers. Interestingly, there were no such correlations with TBARS in the pregnant and postpartum groups.
Conclusions: The present study shows changes in the oxidant/antioxidant balance in saliva during pregnancy and
after birth, which may be affected by periodontal health status in the latter case. Whether this is associated with
adverse pregnancy outcomes, or not, remains to be elucidated. Early identification of ROS markers in saliva may be of
clinical value in the periodontal management of pregnant women.
Keywords: Pregnancy, Saliva, Periodontal disease, Oxidative stress, Reactive oxygen species
Background
Periodontal diseases are a heterogeneous group of infec-
tious/inflammatory diseases that may consequently re-
sult in tooth loss. A local elevation of pro-inflammatory
mediators is caused in the periodontal tissues, which
may lead to reversible inflammation (gingivitis) or to irre-
versible local tissue destruction (periodontitis) [5]. This
local inflammatory response is initiated upon stimulation
by oral bacteria in a form of polymicrobial biofilms grow-
ing on the tooth surface [39].
Significant links have been elucidated between local
inflammatory periodontal disease and systemic conditions,
such as diabetes mellitus and a higher risk of preterm low-
birth weight babies (PLBW) [29]. In this line, many studies
supported a possible bi-directional relationship between
periodontal disease and pregnancy [6, 26]. During pregnancy,
the occurring physiological changes affect the maternal
immune system. This may reflect on the clinical presentation
of both systemic and local infections, such as periodontal
diseases [6, 26]. Reciprocally, it has been discussed that
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periodontal diseases are strongly associated with adverse
pregnancy outcomes [1, 42], supported by studies showing
that PLBW are more common among individuals with
periodontal disease than health [22, 24]. However, others
have failed to find such associations [7, 9, 17, 25].
One of the possible hypotheses to explain the potential
mechanism underlying this interaction could be alter-
ation in the oxidative stress-mediated inflammatory
pathways in periodontal disease and PLBW [6, 26]. Oxi-
dative stress represents an increase in the production of
oxidants and/or a decrease in protective antioxidants.
Oxygen is an essential element of aerobic life and oxida-
tive metabolism and represents a principal source of en-
ergy, but when partially reduced, it generates reactive
oxygen species (ROS) [27]. Hence, an unbalanced equilib-
rium between radical and non-radical ROS can damage
periodontal tissues by a variety of mechanisms, including
peroxidation of lipid membranes, protein inactivation, as
well as stimulation of cytokine production [13, 36].
Large amounts of pro-oxidants are produced in the pro-
longed inflammatory responses, which occur in gingivitis
and periodontitis [44]. Reversely, patients with periodon-
tal disease often present with reduced levels of anti-
oxidants [14, 34]. Therefore, periodontal disease could
contribute to increased local and systemic burden of
ROS in expectant mothers. Yet, multiple sources of
ROS, such as stress, may account in this population. The
aim of the present study was to evaluate in pregnant and
postpartum women the salivary levels of oxidative stress
markers in saliva, and their associations with clinical pa-
rameters of periodontal inflammation and disease severity.
The measurable outcomes were the levels of glutathione
peroxidase (GPx), which is an antioxidant, thiobarbituric
acid-reactive substances (TBARS), a measure of ROS
damage, and 8-hydroxy-2’-deoxyguanosine (8-OHdG), a
measure of DNA damage, in saliva.
Methods
Study population
A total of 187 women participated in this study. These in-
cluded 115 pregnant women (aged 19.0 to 40 years) were
recruited for this study between March 2013 and March
2014, from the project of Municipality of Bornova, Dental
Association and Ege University Ege University Medical
School Department of Public Heatlth, Izmir, Turkey, and a
control group of 72 systemically healthy non-pregnant
women (aged 18.0 to 48 years) seeking dental treatment in
School of Dentistry, Ege University, Izmir, Turkey. General
exclusion criteria were a) any known systemic disease and,
b) periodontal treatment within the last six months, c) pa-
tients having less than 10 teeth, d) smokers, and e) individ-
uals with BMI > 30 kg/m2. Further, additional exclusion
criteria in the pregnant group gestational diabetes mellitus
and preeclampsia. Pregnant women were re-evaluated
6 months after postpartum. The study was conducted in
full accordance with the ethical principles of the World
Medical Association Declaration of Helsinki. The study
was approved by the Ethics Committee of Ege University
(protocol number 13–3.3/8) and conforms to the STROBE
guidelines for observational studies [43]. The study proto-
col was explained to the participants, and written in-
formed consent was obtained from each one of them prior
to registering medical and dental histories, clinical peri-
odontal examination and saliva sampling.
The study design included the following groups: 1)
pregnant women (n = 115) who were in their second tri-
mester (weeks 16–24) or third trimester (weeks 25–34),
2) postpartum women (n = 115) who were evaluated
6 months after giving birth, 3) women who were system-
ically healthy and non-pregnant (n = 72) (control group).
Clinical diagnosis of periodontal health status was fur-
ther performed. Patients were diagnosed with chronic
periodontitis when they had ≥4 teeth in each jaw with a
probing depth (PD) of ≥5 mm and clinical attachment
loss (CAL) of ≥4 mm, in at least two quadrants. Diagno-
sis of gingivitis was assigned when bleeding on probing
(BOP) was present at >50 % of all sites and PD <3 mm
at ≥90 % of the measured sites, but no more than one
site had PD >4 mm and CAL ≤1 mm. The periodontally
healthy women exhibited BOP <20 % of the measured
sites [5, 28]. All participants had ≥20 teeth present.
Collection and processing of saliva samples
Whole saliva samples were obtained simply by expector-
ating into polypropylene tubes prior to clinical periodon-
tal measurements or any periodontal intervention. This
was performed during morning sessions, following an
overnight fast during which subjects were requested not
to drink (except water) or chew gum. The individuals
were asked to rinse their mouth with tap water, before
expectorating whole saliva into sterile 50 ml tubes for
5 min. The saliva samples were then placed on ice, sup-
plemented with EDTA-free Protease Inhibitor Cocktail
(Roche Applied Science, Switzerland) prior to centrifu-
ging at 10000 x g for 15 min at 4 °C. The resulting super-
natants were immediately aliquoted and frozen (−80 °C),
until the analysis.
Clinical periodontal measurements
Subsequent to saliva sampling, clinical periodontal re-
cordings, including dichotomous (+/−) plaque index
(PI), PD, CAL, and dichomotous (+/−) presence of BOP
(occurring within 15 s after periodontal probing) were
performed at 6 sites on each tooth present (except third
molars) using a Williams periodontal probe (Hu Friedy,
Chicago, IL, USA). CAL was assessed from the cement-
enamel junction to the base of the probable pocket. All
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clinical measurements were performed by a single cali-
brated examiner (PG).
Measurement of GPx activity, 8-OHdG and TBARS in saliva
The activity of GPx in saliva supernatants was deter-
mined using the GPx assay kit (HT Glutathione Peroxid-
ase Assay Kit, Cat# 7512-100-K, Trevigen, Gaithersburg,
USA) according to the manufacturer’s instructions. Oxi-
dized glutathione is recycled to its reduced state by gluta-
thione reductase and nicotinamide adenine dinucleotide
phosphate (NADPH). The assay principle is that oxidation
of NADPH to NADP is accompanied by a decrease in ab-
sorbance immediately at 340 nm every 30 s over 12.5 min.
One Unit of GPx was defined as the amount of enzyme
causing oxidation of 1 nM of NADPH to NADP+ per min
at 25 °C.
Lipid peroxidation was measured using thiobarbituric
acid-reactive substances (TBARS) (TBARS Parameter
Assay Kit, Cat# KGE013, R&D, Minneapolis, USA). For
precipitating interfering proteins and other substances,
trichloroacetic acid (TCA) treatment was applied to
the saliva samples. After 15 min incubation at room
temperature, the samples were centrifuged at 21000 x
g for 4 min. The resulting supernatants were incubated
with thiobarbituric acid (TBA) on a thermoshaker at
97 °C for 30 min, and the resulting color was measured
spectophotometrically at 532 nm. The calibration
curve of 1,1,3,3-tetraethoxypropane standard solutions
was used to determine the concentrations of TBA–
MDA in the samples.
Salivary 8-OHdG levels were also measured by an
ELISA kit (OxiSelectTM Oxidative DNA Damage ELISA
Kit, Cat# STA-320, Cell Biolabs, Inc. San Diego, USA),
according to the manufacturer’s instructions. A volume
of 50 μl of saliva or 8-OHdG standard was used for the
assay. At the end-reaction, the absorbance was read
spectrophotometrically at 450 nm, and the concentra-
tions of 8-OHdG in the samples were determined by
comparison against a pre-determined standard curve.
Bacterial quantification by quantitative real-time Polymerase
Chain Reaction (qPCR)
For determining the total bacterial numbers in saliva,
qPCR was employed. In brief, total bacterial DNA was
extracted from 300 μl saliva by the GenElute bacterial
genomic DNA kit (Sigma Aldrich, Buch, Switzerland).
DNA amplification and detection was performed in a
qPCR System (Step One Plus, Applied Biosystems, Life
Technologies, Basel, Switzerland). Twenty ng DNA were
added to each well and the reaction was run using
SYBR® Green PCR Master Mix (Life Technologies, Zug,
Switzerland) in a StepOnePlus™ Real-Time PCR System
(Applied Biosystems) with primers were designed measure
all bacteria (namely universal primers) as previously de-
scribed [2].
Statistical analysis
The distribution of the data was validated by D’Agostino-
Pearson omnibus normality test and statistical analysis
was performed using non-parametric methods. Compari-
sons between all groups were made using the Kruskal-
Wallis test. Statistical analyses were conducted using the
statistical software (GraphPad Prism version 6.00c for
Mac OS X, GraphPad Software, La Jolla California USA),
and statistical significance was considered at p < 0.05. Cor-
relations between parameters were analyzed by Spear-
man’s correlation test.
Results
Clinical findings: periodontal parameters
Clinical periodontal measurements and age of the subjects
among study groups are outlined in Table 1. Patients in the
periodontitis non-pregnant women group were significantly
older than the other groups (P <0.001). In periodontal
health, the percentage of sites with BOP was significantly
lower in the control group, than pregnant and postpartum
groups, whereas in gingivitis, PD was significantly lower in
pregnant and post-partum, than in non-pregnant women
(p < 0.05). In periodontitis, CAL was significantly higher in
non-pregnant, than in pregnant and postpartum women
(p < 0.05).
Biochemical findings: TBARS, GPx and 8-OHdG levels
Further on, the measurement of biochemical markers
for oxidative stress in saliva and serum was considered
in the recruited study population, irrespective of peri-
odontal health status. Salivary TBARS levels were signifi-
cantly lower in post-partum group, than pregnant and
non-pregnant groups (p < 0.0001), while there were no
differences between non-pregnant and pregnant groups
(p = 0.636) (Fig. 1).
Regarding 8-OHdG, the non-pregnant group exhibited
significantly lower levels than pregnant and postpartum
groups (p = 0.034, p = 0.0051, respectively), but there
were no differences between the latter two groups (p =
0.3178) (Fig. 2).
It is of interest note that the levels of GPx were below
detection limits in several samples among the three
study groups (pregnant; n = 93, post-partum; n = 33,
non-pregnant; n = 33). Among detected samples, the
postpartum group exhibited significantly higher GPx
levels than the pregnant and non-pregnant groups (p <
0.0001, p = 0.0034, respectively). Moreover, GPx levels
in the non-pregnant were significantly higher than in
the pregnant group (p < 0.0001) (Fig. 3).
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Table 1 Clinical periodontal measurements of study groups
Groups Pregnant
Healthy
Pregnant
Gingivitis
Pregnant
Periodontitis
Nonpregnant
Healthy
Nonpregnant
Gingivitis
Nonpregnant
Periodontitis
Postpartum
Healthy
Postpartum
Gingivitis
Postpartum
Periodontitis
N: 22 N: 75 N: 18 N: 30 N: 30 N: 12 N: 21 N: 76 N: 18
Median
(IQR)
Median
(IQR)
Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median
(IQR)
Median
(IQR)
Median (IQR) p
Age
(year)
27.9 (6.5) 25.0 (4.0) 31.0 (8.5) a 25.0 (4.0) 23.5 (9.0) 40.0 (10.0) a 27.5 (6.0) 27.0 (8.5) 31.5 (7.3) p <
0.001
PD
(mm)
1.0 (1.0) 2.0 (0.0) b 5.3 (1.0) 1.0 (1.0) c 3.0 (1.0) bd 5.0 (1.0) 1.0 (0.0) c 2.0 (0.0) d 5.0 (1.0) p <
0.001
CAL
(mm)
1.0 (1.0) 2.0 (0.0) 6.2 (1.0) a 1.0 (1.0) 3.0 (1.0) 8.1 (1.0) ae 1.0 (0.0) 2.0 (0.0) 5.0 (1.0) e p <
0.001
BOP
(%)
10.0
(10.0)f
60.0 (60.0) 100.0 (20) 5.0 (10.0) fc 70.0 (15.0) d 90.0 (20.0) 10.0 (5.0) c 50.0 (20.0) d 80.0 (37.5) p <
0.001
PI (%) 15.0 (10.0)
f
70.0 (50.0) 100.0 (10) a 5.0 (5.0) fc 65.0 (20.0) d 70.0 (20.0) ae 10.0 (5.0) c 50.0 (25.0) a 80.0 (30.0) e p <
0.001
PD probing depth, CAL clinical attachment level, BOP bleeding on probing, PI plaque index, IQR Interquartile range
asignificant difference between non-pregnant periodontitis and pregnant periodontitis
bsignificant difference between non-pregnant gingivitis and pregnant gingivitis
csignificant difference between non-pregnant healthy and postpartum healthy
dsignificant difference between non-pregnant gingivitis and postpartum gingivitis
esignificant difference between non-pregnant periodontitis and postpartum periodontitis
fsignificant difference between non-pregnant healthy and pregnant healthy
Fig. 1 TBARS levels in the three study groups. Dot plot of TBARS levels in saliva among the three study groups (pregnant, post-partum, non-pregnant).
Median and IQR were given. TBARS levels are expressed as μM
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Microbiological findings: total bacterial numbers in saliva
The total bacterial number per volume of saliva was also
evaluated. Significant differences were detected among
all pair-wise comparisons between study groups (Fig. 4).
Bacterial numbers were significantly higher in the non-
pregnant group, compared to the pregnant (p < 0.0001)
or the post-partum group (p = 0.0158). Accordingly, the
levels were also significantly higher in the post-partum
compared to the pregnant group (p < 0.0001).
Correlations between parameters
Finally, the associations between biochemical, microbio-
logical and clinical periodontal parameters were evalu-
ated in the three study groups (Table 2). Interestingly, in
the pregnant women group, there were no significant
correlations between biochemical, microbiological and
clinical periodontal data. In the postpartum group, saliv-
ary 8-OHdG levels were positively correlated with PD
and CAL, whereas salivary GPx levels were positively
correlated with PD and BOP. These two oxidative stress
markers were also positively correlated with total bacter-
ial numbers. In the non-pregnant women group, positive
correlations were found between GPx levels and PD,
CAL, BOP or PI. On the contrary, negative correlations
were revealed between TBARS and the same clinical
periodontal measurements.
Discussion
A continuous balance exists in the body between ROS
production and antioxidants. Overproduction of ROS
and insufficiency of antioxidant mechanism results in an
oxidative stress condition, which directly damages cell
structures and molecules, including lipids, proteins and
DNA [10]. It may also be responsible for activating key
nuclear transcription factors that initiate the synthesis of
pro-inflammatory mediators [15]. Conditions in which
oxidative stress has been implicated include periodon-
titis, obesity, type II diabetes, vascular diseases and in
adverse pregnancy outcomes [21]. Pregnancy is a physio-
logical condition with affected lipid profile parameters
[3] and increased oxidative stress [32]. Increased ROS
production beyond the mother’s antioxidant potential
leads to oxidative stress, which can affect the health of
both the mother and fetus, leading to adverse pregnancy
Fig. 2 8-OHdG levels in the three study groups. Dot plot of 8-OHdG levels in saliva among the three study groups (pregnant, post-partum, non-pregnant).
Median and IQR were given. 8-OHdG levels are expressed as ng/mL
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outcomes [32]. With regards to periodontal diseases, the
balance between ROS and the antioxidant defense sys-
tems is postulated as one of the mechanisms responsible
for periodontal tissue breakdown [15].
TBARS is a measure of ROS damage during inflamma-
tion [19], and chronic periodontitis patients are shown
to exhibit higher levels of lipid peroxidation than peri-
odontally healthy individuals [8, 30]. Periodontitis-affected
gingival tissue displays significantly higher TBARS expres-
sion compared to healthy tissue, a finding that could im-
plicate oxidative stress as a biomarker for the disease [8].
Accordingly, TBARS levels in plasma, erythrocytes, or
erythrocyte membranes were found to be higher in pa-
tients with periodontitis than in healthy subjects [30]. It
has also been shown that weight gain during pregnancy is
associated with an increase in TBARS [4]. The present
study demonstrated lower salivary TBARS levels in post-
partum, compared to pregnant women. When considering
the periodontal health status, no association was found be-
tween clinical measurements and TBARS salivary levels in
pregnant and postpartum women. However, a negative
such correlation was revealed in non-pregnant women,
which might suggest periodontal health is commensurate
with a reduced oxidative stress burden. In contrast, the
Fig. 3 GPx levels in the three study groups: Dot plot of GPx levels in saliva among the three study groups (pregnant, postpartum, non-pregnant).
Median and IQR were given. GPx levels are expressed as Units/ml
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Fig. 4 Total bacterial numbers in saliva, in the three study groups. Dot plot of total bacterial numbers per ml of saliva among the three study
groups (pregnant, postpartum, non-pregnant), as defined by qPCR. Median and IQR are given
Table 2 Correlations between biochemical and periodontal data in the study groups
Pregnant Postpartum Non-pregnant
8-OHdG GPx TBARS 8-OHdG GPx TBARS 8-OHdG GPx TBARS
PD (mm) r 0.003 0.068 0.006 0.374 0.198 −0.105 0.070 0.475 −0.352
p 0.974 0.468 0.955 <0001* 0.035* 0.322 0.562 <0001* 0.003*
CAL (mm) r 0.003 −0.052 0.056 0.304 0.083 0.234 −0.020 0.469 −0.286
p 0.978 0.581 0.671 <0001* 0.380 0.543 0.866 <0001* 0.016*
Plaque (%) r −0.018 −0.001 0.076 0.042 0.151 0.048 0.132 0.360 −0.435
p 0.847 0.990 0.475 0.658 0.111 0.655 0.271 <0001* <0001*
BOP (%) r −0.002 0.010 0.087 0.079 0.199 −0.003 0.111 0.437 −0.406
p 0.986 0.914 0.414 0.404 0.035* 0.975 0.358 <0001* <0001*
Total bacteria r 0.073 −0.001 −0.147 0.218 0.287 −0.012 0.131 0.228 −0.175
p 0.437 0.999 0.165 0.018* <0001* 0.905 0.272 0.043* 0.145
* Significant correlations (p < 0.05)
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lack of any such association in pregnant and postpartum
women may denote that the physiological events of preg-
nancy and delivery perturb the oxidative stress status,
therefore masking the putative association of TBARS with
periodontal inflammation or periodontal disease severity.
Hydroxyl radical damage elicited on DNA bases
can be assessed by measuring 8-OHdG levels [16].
Higher salivary and gingival crevicular fluid (GCF) levels
of 8-OHdG were detected in patients with advanced
periodontal destruction, and these were reported to de-
crease after periodontal treatment [11, 18, 35, 37, 38, 40, 41].
In the present study, non-pregnant women exhib-
ited lower levels of 8-OHdG levels than pregnant or
postpartum women. This indicates that physiological
states of pregnancy and delivery increase ROS in the oral
environment, as determined by 8-OHdG. This result
may be well in line with earlier studies showing signifi-
cantly elevated urine 8-OHdG concentrations during the
third trimester of pregnancy [33]. In another study
where urine 8-OHdG was measured once during 24–26
weeks of gestation, its concentrations proved to be
higher in women who delivered a low birth-weight in-
fant, although there was no association with preterm
birth [23]. Interestingly, only in the postpartum group
there was a positive association confirmed between this
marker and periodontal disease severity (PD and CAL)
and salivary bacterial load, but not with BOP. This associ-
ation may indicate that following birth, oxidative stress
burden may be exacerbated in the presence of periodontal
disease. In this line, earlier studies have shown that salivary
[35, 41] and GCF [18] 8-OHdG levels correlated with
measurements of periodontal tissue destruction, particu-
larly in chronic periodontitis [35].
A further molecule investigated in this study was GPx,
an intracellular and extracellular DNA protective en-
dogenous antioxidant [31]. GPx levels have been shown
to increase by the severity of periodontal disease, while
its levels decrease after nonsurgical periodontal treat-
ment [8, 30, 44]. In pre-eclamptic women, GCF and
serum GPx levels were found to be lower in the pres-
ence of periodontal disease [12]. Here, we found that
GPx levels in saliva were low during pregnancy, whereas
they were increased again postpartum. The increase of
antioxidant levels immediately after birth may be a com-
pensatory mechanism, particularly after a long period of
exposure to increased ROS during pregnancy. When
considering the periodontal disease status, no associ-
ation was found with GPx in pregnant women. However,
there was a positive correlation with PD, BOP and total
bacterial numbers in postpartum and non-pregnant
women. On the contrary, an earlier study found a nega-
tive correlation between GPx levels and PD or CAL, par-
ticularly in periodontitis [20]. The reason for this
discrepancy is not clear. Yet, in the case of postpartum
women, the increased GPx antioxidant levels may com-
pensate for the sustained ROS levels during pregnancy.
Hence, the association between GPx and periodontal
disease severity observed here may be attributed to a
disequilibrium between ROS and anti-oxidants.
Conclusion
This is the first study to evaluate oxidative stress markers
in saliva, represented by TBARS, GPx and 8-OHdG, in
women during pregnancy and postpartum, and consider
their association with the severity of periodontal tissue de-
struction. TBARS, a measure of ROS damage was elevated
during pregnancy. Contrary, the antioxidant GPx was ele-
vated postpartum, possibly to compensate for prior ROS
increase. These findings clearly highlight the increased
oxidative stress during pregnancy, and the dynamics de-
veloping for its compensation after birth. Yet, the associ-
ation of these markers with adverse pregnancy outcomes
cannot be deduced by this study. When periodontal dis-
ease status is taken into consideration, assessed by clinical
periodontal parameters, there is no association with any of
the studied markers during pregnancy. However, during
the postpartum period positive correlations were revealed
for both 8-OHdG and GPx. Hence these findings indicate
that women in the postpartum period undergo a consider-
able oxidative stress salivary disequilibrium, and a deterio-
rated periodontal disease status may be a contributing
factor to this.
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